These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34865569)

  • 1. Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors.
    Supuran CT
    Expert Opin Investig Drugs; 2021 Dec; 30(12):1197-1208. PubMed ID: 34865569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.
    Supuran CT
    Expert Opin Investig Drugs; 2018 Dec; 27(12):963-970. PubMed ID: 30426805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing carbonic anhydrase inhibitors for the treatment of breast cancer.
    Supuran CT; Winum JY
    Expert Opin Drug Discov; 2015 Jun; 10(6):591-7. PubMed ID: 25891195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).
    Nocentini A; Supuran CT
    Expert Opin Ther Pat; 2018 Oct; 28(10):729-740. PubMed ID: 30074415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.
    Carta F; Vullo D; Osman SM; AlOthman Z; Supuran CT
    Bioorg Med Chem; 2017 May; 25(9):2569-2576. PubMed ID: 28347633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment.
    Angeli A; Carta F; Nocentini A; Winum JY; Zalubovskis R; Akdemir A; Onnis V; Eldehna WM; Capasso C; Simone G; Monti SM; Carradori S; Donald WA; Dedhar S; Supuran CT
    Metabolites; 2020 Oct; 10(10):. PubMed ID: 33066524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX.
    Mondal UK; Doroba K; Shabana AM; Adelberg R; Alam MR; Supuran CT; Ilies MA
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors.
    Supuran CT
    J Exp Pharmacol; 2020; 12():603-617. PubMed ID: 33364855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of first-in-class multi-target adenosine A
    Ceni C; Catarzi D; Varano F; Ben DD; Marucci G; Buccioni M; Volpini R; Angeli A; Nocentini A; Gratteri P; Supuran CT; Colotta V
    Eur J Med Chem; 2020 Sep; 201():112478. PubMed ID: 32659606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.
    Lomelino CL; Mahon BP; McKenna R; Carta F; Supuran CT
    Bioorg Med Chem; 2016 Mar; 24(5):976-81. PubMed ID: 26810836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site.
    Singh S; Lomelino CL; Mboge MY; Frost SC; McKenna R
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29710858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities.
    Elbadawi MM; Eldehna WM; Nocentini A; Abo-Ashour MF; Elkaeed EB; Abdelgawad MA; Alharbi KS; Abdel-Aziz HA; Supuran CT; Gratteri P; Al-Sanea MM
    Eur J Med Chem; 2021 Jun; 218():113360. PubMed ID: 33773285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents.
    Eldehna WM; Abo-Ashour MF; Nocentini A; El-Haggar RS; Bua S; Bonardi A; Al-Rashood ST; Hassan GS; Gratteri P; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2019 Jan; 162():147-160. PubMed ID: 30445264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
    Guler OO; De Simone G; Supuran CT
    Curr Med Chem; 2010; 17(15):1516-26. PubMed ID: 20166929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).
    Monti SM; Supuran CT; De Simone G
    Expert Opin Ther Pat; 2013; 23(6):737-49. PubMed ID: 23672415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
    Carradori S
    Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
    Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
    Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents.
    Krasavin M; Kalinin S; Sharonova T; Supuran CT
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1555-1561. PubMed ID: 32746643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.
    Dar'in D; Kantin G; Kalinin S; Sharonova T; Bunev A; Ostapenko GI; Nocentini A; Sharoyko V; Supuran CT; Krasavin M
    Eur J Med Chem; 2021 Oct; 222():113589. PubMed ID: 34147910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.